Fundraising FoxTriple Impact Capital — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Kanvas Bio operates a platform for discovering, developing, and manufacturing live biotherapeutics based on the human gut microbiome.
BiotechDeep TechHealthtechMonmouth Junction, US
Matthew Cheng(Executive Officer, Director)inHao Shi(Executive Officer, Director)inIwijn De Vlaminck(Executive Officer, Director)in
BoardJason Pontin(Director)in
Board seatJustin Smithline· per SEC Form D · $12M raise · filed Jun 2023
Co-investorsAlumni VenturesBascom VenturesBoutique Venture PartnersDCVC (Data Collective)FemHealth VenturesGermin8 Ventures+5 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.